Jeremy P. Steele
St Bartholomew's Hospital
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical Trial.
Journal: JAMA oncology
Published: February 15, 2024
Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial.
Journal: The Lancet. Respiratory medicine
Published: November 17, 2023
Correction: A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma.
Journal: Pharmacological reports : PR
Published: May 17, 2023
Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome.
Journal: European journal of human genetics : EJHG
Published: April 26, 2023
A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma.
Journal: Pharmacological reports : PR
Published: January 23, 2023
Phase 1, pharmacogenomic, dose-expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1-deficient non-squamous non-small cell lung cancer.
Journal: Cancer medicine
Published: February 19, 2021
Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1-Deficient Mesothelioma: Safety, Efficacy, and Resistance Mechanisms.
Journal: JTO clinical and research reports
Published: August 26, 2020
BTS guideline for the investigation and management of malignant pleural mesothelioma.
Journal: BMJ open respiratory research
Published: November 30, 2017
Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 08, 2017
Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial.
Journal: JAMA oncology
Published: September 02, 2016
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience.
Journal: The Journal of thoracic and cardiovascular surgery
Published: March 30, 2014
Last Updated: 09/26/2026